fAI-BRO:多模态AI决策支持系统用于减少纤维肌痛综合征诊断延迟
该横断面概念验证研究在100例患者中评估多模态AI系统fAI-BRO区分纤维肌痛综合征(FMS)与其他风湿肌肉骨骼疾病(RMDs)的准确性。fAI-BRO基于视频视觉描述符(30%权重)和心理语言学转录特征(70%权重)评分,FMS检测准确率91%,敏感度94%,特异度88%,AUC 0.96,患者接受度高,但事后优化阈值需外部验证。
要点
- fAI-BRO对FMS检测准确率91%、敏感度94%、特异度88%、AUC 0.96。
- 所有炎症性关节炎和机械性疾病对照均正确分类为RMD。
- 6例FMS假阳性均见于皮肌炎和多肌痛风湿症。
核心结论
- fAI-BRO作为人在环路中的决策支持工具,对FMS筛查显示出有前景的诊断准确性。
- 炎症性关节炎分类完美且患者接受度高,但事后优化阈值需外部验证后方可临床部署。
研究设计与样本
- 横断面概念验证研究,在意大利巴里大学纳入100例患者,包括50例符合ACR 2016标准的FMS和50例RMD对照(炎症性关节炎、骨关节炎及其他情况)。
- 患者接受意大利语标准化访谈,音频经OpenAI Whisper翻译模式处理,Magistral-Small模型以零样本配置本地部署,分析四帧视频图像描述符(30%权重)和心理语言学转录特征(70%权重)。
- 分类阈值通过Youden J指数事后优化。
主要发现
- 在100例患者中,fAI-BRO基于0-100综合评分检测FMS的准确率为91%(敏感度94%,95%CI 83.5%至98.7%;特异度88%,95%CI 75.7%至95.5%;AUC 0.96)。
- Youden J指数确定经验最优切点为47,向下取整至45以偏向筛查敏感度。
- 所有炎症性关节炎病例(类风湿关节炎、银屑病关节炎、脊柱关节炎、系统性红斑狼疮;n=36)和机械性疾病(骨关节炎、撞击综合征;n=8)均被正确分类为RMD。
- 6例FMS假阳性均发生于皮肌炎(n=3)和多肌痛风湿症(n=3),作者提出这涉及肌肉组织而非滑膜病理的重叠假设。
- 扰动分析确认广泛性疼痛描述符是主要分类驱动因素,二分类对英语翻译效应稳健,患者舒适度高(平均4.5/5),平均处理时间324秒。
关键数值与推荐
- FMS诊断依据ACR 2016标准。
- FMS检测准确率91%,敏感度94%(95%CI 83.5%至98.7%),特异度88%(95%CI 75.7%至95.5%),AUC 0.96。
- 综合评分0-100分,经验最优切点47,取整为45。
- 视频图像描述符权重30%,心理语言学转录特征权重70%。
临床怎么用
- fAI-BRO可作为人在环路中的决策支持工具用于FMS筛查,帮助减少诊断延迟。
- 当前阈值经事后优化,临床部署前需外部验证。
- 对皮肌炎和多肌痛风湿症患者需注意FMS假阳性可能。
局限性
- 事后优化的分类阈值需外部验证后方可临床部署。
- 研究为单中心横断面概念验证,样本量100例。
- 假阳性集中于皮肌炎和多肌痛风湿症,作者仅作为假设生成性观察。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the diagnostic accuracy and patient acceptability of fAI-BRO (Fibromyalgia AI-Based Rheumatology Observer), a multimodal artificial intelligence (AI) system integrating video-based visual descriptor analysis and psycholinguistic transcript evaluation, for distinguishing fibromyalgia syndrome (FMS) from other rheumatic and musculoskeletal diseases (RMDs). METHODS: In this cross-sectional proof-of-concept study, 100 patients at the University of Bari (50 FMS per ACR (American College of Rheumatology) 2016 criteria, 50 RMD controls including inflammatory arthritis, osteoarthritis and other conditions) underwent standardised interviews in Italian. Audio was processed with OpenAI Whisper in translate mode. Magistral-Small (Mistral AI), deployed locally in zero-shot configuration without FMS-specific fine-tuning or in-context examples, analysed four video frames using OpenCV-derived image-level descriptors (30% weight) and psycholinguistic transcript features (70% weight). Classification thresholds were optimised post hoc via Youden's J index. RESULTS: Among 100 patients, fAI-BRO achieved 91% accuracy (94% sensitivity (95% CI 83.5% to 98.7%), 88% specificity (95% CI 75.7% to 95.5%), area under the curve 0.96) for FMS detection on a 0-100 composite score. Youden's J identified the empirically optimal cut-off at 47, rounded down to 45 to favour screening sensitivity. All inflammatory arthritis cases (rheumatoid arthritis (RA), psoriatic arthritis (PsA), spondyloarthritis (SpA), systemic lupus erythematosus (SLE); n=36) and mechanical conditions (OA, impingement; n=8) were correctly classified as RMD. All six false positives for FMS occurred in dermatomyositis (n=3) and polymyalgia rheumatica (n=3)-a biologically plausible overlap involving muscle tissue rather than synovial pathology, presented here as a hypothesis-generating observation rather than incidental noise. Perturbation analysis confirmed widespread pain descriptors as the dominant classification drivers. Binary classification was robust to the English translation effect. Patient comfort was high (mean 4.5/5). Mean processing time was 324 s. CONCLUSION: fAI-BRO demonstrates promising diagnostic accuracy for FMS screening as a human-in-the-loop decision-support tool, with perfect inflammatory arthritis classification and high patient acceptability. Post hoc optimised thresholds require external validation before clinical deployment.
引用
- Venerito V, Lopalco G, Morrone M, et al. fAI-BRO: a multimodal AI decision-support system to address diagnostic delay in fibromyalgia syndrome. RMD Open. 2026. PMID: 42442924. doi:10.1136/rmdopen-2026-006995
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。